LOCK-UP AND NO SHORTING AGREEMENTLock-Up and No Shorting Agreement • March 28th, 2017 • Kearny Venture Partners LP • Pharmaceutical preparations • New York
This LOCK-UP AND NO SHORTING AGREEMENT (this “Agreement”) is made as of March 15, 2017, by and between the undersigned person or entity (the “Restricted Holder”) and Aerpio Pharmaceuticals, Inc. (formerly known as Zeta Acquisition Corp. II), a Delaware corporation (the “Parent”). Capitalized terms used and not otherwise defined herein shall have the meanings given to such terms in the Merger Agreement (as defined below).
Agreement of Joint FilingAgreement of Joint • March 28th, 2017 • Kearny Venture Partners LP • Pharmaceutical preparations
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Aerpio Pharmaceuticals, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
Agreement of Joint FilingAgreement of Joint Filing • January 30th, 2017 • Kearny Venture Partners LP • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of ViewRay, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
Agreement of Joint FilingAgreement of Joint Filing • May 25th, 2018 • Kearny Venture Partners LP • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of ViewRay, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
